genOway Société anonyme (ALGEN.PA)

EUR 3.92

(0.0%)

Total Assets Summary of genOway Société anonyme

  • genOway Société anonyme's latest annual total assets in 2023 was 31.84 Million EUR , down -2.32% from previous year.
  • genOway Société anonyme's latest quarterly total assets in 2023 FY was 31.84 Million EUR , down -2.32% from previous quarter.
  • genOway Société anonyme reported annual total assets of 32.59 Million EUR in 2022, up 0.31% from previous year.
  • genOway Société anonyme reported annual total assets of 32.49 Million EUR in 2021, up 18.87% from previous year.
  • genOway Société anonyme reported quarterly total assets of 32.32 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • genOway Société anonyme reported quarterly total assets of 31.84 Million EUR for 2023 FY, down -2.32% from previous quarter.

Annual Total Assets Chart of genOway Société anonyme (2023 - 2009)

Historical Annual Total Assets of genOway Société anonyme (2023 - 2009)

Year Total Assets Total Assets Growth
2023 31.84 Million EUR -2.32%
2022 32.59 Million EUR 0.31%
2021 32.49 Million EUR 18.87%
2020 27.33 Million EUR 42.74%
2019 19.15 Million EUR -2.72%
2018 19.68 Million EUR 14.68%
2017 17.16 Million EUR 46.73%
2016 11.7 Million EUR 8.58%
2015 10.77 Million EUR 3.84%
2014 10.37 Million EUR 6.46%
2013 9.74 Million EUR -7.5%
2012 10.53 Million EUR -4.27%
2011 11 Million EUR -3.69%
2010 11.42 Million EUR 2.33%
2009 11.16 Million EUR 0.0%

Peer Total Assets Comparison of genOway Société anonyme

Name Total Assets Total Assets Difference
ABIONYX Pharma SA 14.71 Million EUR -116.468%
ABIVAX Société Anonyme 327.06 Million EUR 90.264%
Adocia SA 24.95 Million EUR -27.594%
Aelis Farma SA 26.28 Million EUR -21.161%
Biophytis S.A. 11.93 Million EUR -166.776%
Advicenne S.A. 12.4 Million EUR -156.648%
IntegraGen SA 8 Million EUR -298.012%
Medesis Pharma S.A. 1.92 Million EUR -1553.003%
Neovacs S.A. 47.53 Million EUR 33.011%
NFL Biosciences SA 3.97 Million EUR -701.948%
Plant Advanced Technologies SA 14.91 Million EUR -113.522%
Quantum Genomics Société Anonyme 3.74 Million EUR -749.862%
Sensorion SA 46.49 Million EUR 31.513%
Theranexus Société Anonyme 7.23 Million EUR -339.949%
TME Pharma N.V. 2.49 Million EUR -1178.297%
Valbiotis SA 33.24 Million EUR 4.228%
TheraVet SA 7.53 Million EUR -322.638%
Valerio Therapeutics Société anonyme 35.27 Million EUR 9.728%
argenx SE 4.11 Billion EUR 99.226%
BioSenic S.A. 9.55 Million EUR -233.114%
Celyad Oncology SA 16.28 Million EUR -95.568%
DBV Technologies S.A. 165.65 Million USD 80.777%
Galapagos NV 4.35 Billion EUR 99.269%
Genfit S.A. 173.87 Million EUR 81.686%
GeNeuro SA 6.31 Million EUR -404.402%
Hyloris Pharmaceuticals SA 47.68 Million EUR 33.218%
Innate Pharma S.A. 184.19 Million EUR 82.712%
Inventiva S.A. 69.13 Million EUR 53.944%
MaaT Pharma SA 42.93 Million EUR 25.829%
MedinCell S.A. 36.94 Million EUR 13.818%
Nanobiotix S.A. 93.89 Million EUR 66.088%
Onward Medical N.V. 43.62 Million EUR 27.016%
Oryzon Genomics S.A. 106.9 Million EUR 70.213%
OSE Immunotherapeutics SA 81.9 Million EUR 61.12%
Oxurion NV 6.55 Million EUR -386.143%
Pharming Group N.V. 426.33 Million EUR 92.531%
Poxel S.A. 4.82 Million EUR -560.219%
GenSight Biologics S.A. 9.08 Million EUR -250.417%
Transgene SA 45.21 Million EUR 29.579%
Financière de Tubize SA 1.92 Billion EUR 98.342%
UCB SA 15.53 Billion EUR 99.795%
Valneva SE 469.39 Million EUR 93.216%
Vivoryon Therapeutics N.V. 30.82 Million EUR -3.287%